SEC Info - Portola Pharmaceuticals Inc - ‘S-3ASR’ on 11/9/15

SEC Info℠

Home

Help

Please Sign In

Portola Pharmaceuticals Inc – ‘S-3ASR’ on 11/9/15 – EX-23.1

On: Monday, 11/9/15, at 5:09pm ET · Effective: 11/9/15 · Accession #: 1193125-15-372129 · File #: 333-207901

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/09/15  Portola Pharmaceuticals Inc       S-3ASR     11/09/15    8:903K                                   RR Donnelley/FA

Automatic Shelf Registration Statement for Securities of a Well-Known Seasoned Issuer — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3ASR      Automatic Shelf Registration Statement for          HTML    211K 
                          Securities of a Well-Known Seasoned                    
                          Issuer                                                 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML    211K 
 3: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     76K 
 4: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     77K 
 5: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     70K 
 6: EX-5.1      Opinion re: Legality                                HTML     25K 
 7: EX-12.1     Statement re: Computation of Ratios                 HTML     19K 
 8: EX-23.1     Consent of Experts or Counsel                       HTML      6K

EX-23.1 — Consent of Experts or Counsel

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Portola Pharmaceuticals, Inc. for the registration of common stock, preferred stock, debt securities and warrants and to the incorporation by reference therein of our reports dated March 2, 2015, with respect to the consolidated financial statements of Portola Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Portola Pharmaceuticals, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2014, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Redwood City, California

November 9, 2015

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-3ASR’ Filing	Date	Other Filings

Filed on / Effective on:	11/9/15	8-K
	3/2/15	10-K, 8-K, S-8
	12/31/14	10-K
		List all Filings

↑Top

Filing Submission 0001193125-15-372129 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)